Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus - PubMed (original) (raw)
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus
Casandra C van Bavel et al. Ann Rheum Dis. 2011 Jan.
Abstract
Objectives: In systemic lupus erythematosus (SLE) apoptotic chromatin is present extracellularly, which is most likely the result of disturbed apoptosis and/or insufficient removal. Released chromatin, modified during apoptosis, activates the immune system resulting in the formation of autoantibodies. A study was undertaken to identify apoptosis-induced histone modifications that play a role in SLE.
Methods: The lupus-derived monoclonal antibody BT164, recently established by selection using apoptotic nucleosomes, was analysed by ELISA, western blot analysis and immunofluorescence staining using chromatin, cells, plasma and renal sections. Random peptide phage display and peptide inhibition ELISA were used to identify precisely the epitope of BT164. The reactivity of plasma samples from lupus mice and patients with SLE with the epitope of BT164 was investigated by peptide ELISA.
Results: The epitope of BT164 was mapped in the N-terminal tail of histone H3 (27-KSAPAT-32) and included the apoptosis-induced trimethylation of K27. siRNA-mediated silencing of histone demethylases in cultured cells resulted in hypermethylation of H3K27 and increased nuclear reactivity of BT164. This apoptosis-induced H3K27me3 is a target for autoantibodies in patients and mice with SLE and is present in plasma and in glomerular deposits.
Conclusion: In addition to previously identified acetylation of histone H4, H2A and H2B, this study shows that trimethylation of histone H3 on lysine 27 is induced by apoptosis and associated with autoimmunity in SLE. This finding is important for understanding the autoimmune response in SLE and for the development of translational strategies.
Similar articles
- Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies.
van Bavel CC, Dieker J, Muller S, Briand JP, Monestier M, Berden JH, van der Vlag J. van Bavel CC, et al. Mol Immunol. 2009 Dec;47(2-3):511-6. doi: 10.1016/j.molimm.2009.08.009. Epub 2009 Sep 10. Mol Immunol. 2009. PMID: 19747733 - Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus.
Dieker JW, Fransen JH, van Bavel CC, Briand JP, Jacobs CW, Muller S, Berden JH, van der Vlag J. Dieker JW, et al. Arthritis Rheum. 2007 Jun;56(6):1921-33. doi: 10.1002/art.22646. Arthritis Rheum. 2007. PMID: 17530637 - Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes.
van Bavel CC, Dieker JW, Tamboer WP, van der Vlag J, Berden JH. van Bavel CC, et al. Mol Immunol. 2010 Nov-Dec;48(1-3):248-56. doi: 10.1016/j.molimm.2010.08.003. Mol Immunol. 2010. PMID: 20817300 - Lupus nephritis: a nucleosome waste disposal defect?
Berden JH, Grootscholten C, Jürgen WC, van der Vlag J. Berden JH, et al. J Nephrol. 2002 Nov-Dec;15 Suppl 6:S1-10. J Nephrol. 2002. PMID: 12515368 Review.
Cited by
- Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus.
Rother N, van der Vlag J. Rother N, et al. Front Immunol. 2015 Nov 30;6:610. doi: 10.3389/fimmu.2015.00610. eCollection 2015. Front Immunol. 2015. PMID: 26648939 Free PMC article. Review. - Perspectives on epigenetic-based immune intervention for rheumatic diseases.
Gray SG. Gray SG. Arthritis Res Ther. 2013 Mar 14;15(2):207. doi: 10.1186/ar4167. Arthritis Res Ther. 2013. PMID: 23510070 Free PMC article. Review. - Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice.
Dieker J, Hilbrands L, Thielen A, Dijkman H, Berden JH, van der Vlag J. Dieker J, et al. Arthritis Res Ther. 2015 Apr 16;17(1):103. doi: 10.1186/s13075-015-0617-2. Arthritis Res Ther. 2015. PMID: 25886192 Free PMC article. - Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.
Mistry P, Kaplan MJ. Mistry P, et al. Clin Immunol. 2017 Dec;185:59-73. doi: 10.1016/j.clim.2016.08.010. Epub 2016 Aug 9. Clin Immunol. 2017. PMID: 27519955 Free PMC article. Review. - A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
van Dam LS, Osmani Z, Kamerling SWA, Kraaij T, Bakker JA, Scherer HU, Rabelink TJ, Voll RE, Alexander T, Isenberg DA, van Kooten C, Teng YKO. van Dam LS, et al. Rheumatology (Oxford). 2020 Oct 1;59(10):2734-2745. doi: 10.1093/rheumatology/kez623. Rheumatology (Oxford). 2020. PMID: 31951278 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical